|Economy||Measure Code||Measure||Currency Code||Amount (Local)||Amount (USD)||Source||Post Date||Details|
|European Central Bank||03||03 - Direct long-term lending||EUR|
|European Central Bank||03A||03A - Long-term lending||EUR|
|European Central Bank||03B||03B - Forbearance||EUR|
|European Central Bank||05||05 - Health and income support||EUR|
|European Central Bank||05A||05A - Health support||EUR|
|European Central Bank||05B||05B - Income support||EUR|
|European Central Bank||05B1||05B1 - Tax and contribution deferrals and policy changes||EUR|
|European Central Bank||05B2||05B2 - Tax and contribution rates reduction||EUR|
|European Central Bank||05B3||05B3 - Subsidies to individuals and households||EUR|
|European Central Bank||05B4||05B4 - Subsidies to businesses||EUR|
|European Central Bank||05B5||05B5 - Indirect income support||EUR|
|European Central Bank||05B6||05B6 - No breakdown (income support)||EUR|
|European Central Bank||05C||05C - No breakdown (health and income support)||EUR|
|European Union||03||03 - Direct long-term lending||EUR||251,902,500,000||278,653,207,965|
|European Union||03A||03A - Long-term lending||EUR||251,902,500,000||278,653,207,965||OECD. http://www.oecd.org/coronavirus/en/#country-tracker (accessed 15 April 2020); EIB. https://www.eib.org/en/press/all/2020-346-ing-and-eib-group-come-to-the-aid-of-dutch-smes-and-mid-caps-during-covid-19 (accessed 7 December 2020); EIB. https://www.eib.org/en/press/all/2020-103-eib-backs-eur5-billion-investment-to-mitigate-economic-impact-of-coronavirus-and-support-medical-technology (accessed 29 April 2020); Yale. https://som.yale.edu/faculty-research-centers/centers-initiatives/program-on-financial-stability/covid-19-crisis (accessed 29 April 2020); EIB. https://www.eib.org/en/press/all/2020-126-eib-board-approves-eur-25-billion-pan-european-guarantee-fund-to-respond-to-covid-19-crisis (accessed 18 December 2020); EIB. https://www.eib.org/en/about/initiatives/covid-19-response/index.htm (accessed 18 July 2020); EIB. https://www.eib.org/en/press/all/2020-197-eib-approves-eur-16-6-billion-for-covid-19-health-response-and-economic-resilience-climate-clean-transport-energy-and-housing (accessed 18 July 2020); EIB. https://www.eib.org/en/press/all/2020-199-eib-provides-eur205-million-to-adif-alta-velocidad-to-promote-the-development-of-rail-infrastructure-in-spain (accessed 23 July 2020); EIB. https://www.eib.org/en/press/all/2020-198-italy-eib-provides-eur300-million-to-autonomous-province-of-trento-for-sustainable-projects-and-post-covid-19-reconstruction (accessed 23 July 2020); EIB. https://www.eib.org/en/press/all/2020-200-eib-backs-826-mw-mytilineos-power-plant-to-support-greek-energy-transition (accessed 23 July 2020); EIB. https://www.eib.org/en/press/all/2020-213-eib-supports-the-reconstruction-of-major-roads-in-montenegro-with-eur40-million (accessed 8 August 2020); EIB. https://www.eib.org/en/press/all/2020-237-italy-eib-lends-eur500m-to-the-lazio-region-for-smes-mid-caps-infrastructure-environment-and-post-covid-19-recovery (accessed 18 September 2020); EIB. https://www.eib.org/en/press/all/2020-238-eib-and-idf-sign-eur50-million-loan-to-support-faster-post-covid-recovery-of-smes-and-mid-caps-in-montenegro (accessed 19 September 2020); ECB. https://www.eib.org/en/press/all/2020-242-eib-approves-eur-12-6-billion-financing-for-transport-clean-energy-urban-development-and-covid-19-resilience (accessed 19 September 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/IP_20_1773 (accessed 3 October 2020); EIB. https://www.eib.org/en/press/all/2020-254-eib-and-hbor-ag+L15ree-on-covid-19-recovery-package-for-croatian-smes-and-mid-caps (accessed 13 October 2020); ECB. https://www.bankingsupervision.europa.eu/press/pr/date/2020/html/ssm.pr200917~eaa01392ca.en.html (accessed 19 September 2020); EIB. https://www.eib.org/en/press/all/2020-274-eib-approves-eur-5-1-billion-for-covid-19-resilience-clean-energy-rail-transport-and-urban-development (accessed 17 October 2020). EIB. https://www.eib.org/en/press/all/2020-342-eib-supports-hungarian-healthcare-sector-during-covid-19-pandemic-with-eur162-5-million (accessed 4 December 2020); EIB. https://www.eib.org/en/press/all/2020-372-eib-group-backs-eur-12-5-billion-covid-19-support-business-clean-energy-transport-and-urban-investment (accessed 5 January 2021); EIB. https://www.eib.org/en/press/all/2021-020-eib-group-and-btv-join-forces-to-provide-additional-lending-to-smes-and-mid-caps (accessed 22 January 2021).||
(i) March 2020, the EIB dedicated EUR10 billion in asset-backed securities (ABS) purchasing programs to allow banks to transfer risk on portfolios of SME loans. 10 December 2020: The EIB and EIF issued a EUR795 million guarantee to ING, which will support new lending to Dutch SMEs and Mid-Caps to mitigate impact from COVID-19; (ii) 23 April 2020, Approved EUR5 billion in new financing for businesses affected by the coronavirus, and for the development of medical technology. EUR3 billion was dedicated to businesses in Spain and Italy. The approval represents an extension of the loan package first identified on 16 March 2020; (iii) 26 May 2020, the Board of Directors of the European Investment Bank (EIB) agreed on the structure and business approach of the new Pan-European Guarantee Fund (EGF) to tackle the economic consequences of the COVID-19 pandemic. It will enable the EIB Group to scale up its support for mostly small and medium-sized European companies, providing up to EUR200 billion of additional financing. Under this scheme, EIB on 15 and 13 July 2020 respectively, financed ZANINI Auto Group's innovation strategy with EUR25 million loan and provided Santander (Spanish commercial bank) with EUR757 million to help support SMEs and mid-caps; (iv) 15 July 2002, EUR14.7 billion from a EUR16.6 billion EIB approved amount (less EUR1.9 billion for Egypt's transport and SME sectors) for COVID-19 health response and economic resilience, climate, clean transport, energy and housing; (v) 21 July 2020, EIB provided EUR205 million in loans to Adif Alta Velocidad (Spanish rail network) to promote the development of rail infrastructure; (vi) 21 July 2020, EIB provided EUR300 million in loans to the Autonomous Province of Trento for sustainable projects and post-COVID-19 reconstruction; (vii) 22 July 2020, EIB provided EUR125 million in loans for Greece's 826 MW Mytilineos power plant to support energy transition; (viii) 31 July 2020, EIB signed a second tranche worth EUR40 million for the rehabilitation of 180 kilometers of road along the five main routes in Montenegro. The loan from the EU bank is complemented by a EUR1.5 million technical assistance grant awarded under the Economic Resilience Initiative (ERI). It is the first ERI grant to be awarded to a project in the Western Balkans. The total EIB investment worth EUR80 million is expected to increase road safety and efficiency and facilitate faster economic recovery and regional trade; (ix) 11 September 2020, EIB lends EUR500 million to the Lazio Region for SMEs, mid-caps, infrastructure, environment and post COVID-19 recovery; (x) 14 September 2020, Montenegrin SMEs and mid-caps in tourism and other sectors severely affected by COVID-19 will benefit from EUR50 million loan that the EIB has signed with the Montenegrin Investment and Development Fund; (xi) 18 September 2020, EIB approves EUR12.6 billion financing for transport, clean energy, urban development and COVID-19 resilience; (xii) 1 October 2020, The EIB Group has provided a mezzanine tranche guarantee of around EUR125 million to Germany’s Commerzbank AG on loans to SMEs and mid-caps to mitigate the impact of the COVID-19 crisis; (xiii) 1 October 2020, The EIB will invest EUR100 million to support COVID-19 recovery of Croatian SMEs and mid-caps; (xiv) 13 October 2020, EIB approved a EUR1 billion direct lending support for companies and health investment in EU member states most impacted by COVID-19 and a EUR2.1 billion to support private sector investment with global financing partners. 4 December 2020, The EIB will invest EUR162.5 million to support the Hungarian healthcare sector’s response to the COVID-19 pandemic. (xvi) 16 December 2020, The EIB approved new financing totaling EUR12.5 billion to support companies impacted by COVID-19, alongside accelerating renewable energy, sustainable transport and urban investment across Europe and around the world. This includes EUR4.1 billion to strengthen public health and private sector resilience to the COVID-19 pandemic. New EIB financing will support medical and pharmaceutical innovation, including testing and treatment, hospital and public health investment and local business lending programs to help companies in sectors most impacted by the pandemic; (xvii) 19 January 2021, EIB Group synthetic securitization of around EUR130 million to enable BTV to lend more than EUR400 million to small and mid-sized businesses in Austria and Germany in response to COVID-19. The operation is backed by the European Fund for Strategic Investments (EFSI) guarantee under the Investment Plan for Europe.
|European Union||03B||03B - Forbearance||EUR|
|European Union||05||05 - Health and income support||EUR||16,410,000,000||18,152,654,867|
|European Union||05A||05A - Health support||EUR||11,283,000,000||12,481,194,690||OECD. http://www.oecd.org/coronavirus/en/#country-tracker (accessed 15 April 2020); EC. https://www.consilium.europa.eu/en/press/press-releases/2020/09/11/addressing-covid-19-council-approves-6-2-billion-budget-increase-for-2020/ (accessed 12 September 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1671 (accessed 21 September 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1680 (accessed 21 September 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1416 (accessed 1 August 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1829 (accessed 10 October 2020); EIB. https://www.eib.org/en/press/all/2020-271-covid-19-eib-provides-eur50-million-to-navarre-to-strengthen-its-health-response-to-covid-19 (accessed 15 October 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2041 (accessed 20 January 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2136 (accessed 21 November 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2200 (accessed 28 November 2020); Council of the EU. https://www.consilium.europa.eu/en/press/press-releases/2020/12/07/council-greenlights-temporary-vat-relief-on-covid-19-vaccines-and-test-kits/ (accessed 7 December 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_50 (accessed 15 January 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_51 (accessed 20 January 2021).||
(i) 13 March 2020, EUR800 million of the EU Solidarity Fund will be available by including a public health crisis within its scope, with a view of mobilizing it if needed for the hardest-hit EU member states; (ii) 19 March 2020, The European Commission (EC) decided to create a European civil protection stockpile of medical equipment (initial budget of EUR50 million, proposed to increase to EUR80 million) with a 90% Commission grant; (iii) 2 April 2020, The EC presented legislative proposals for an Emergency Support Instrument for the healthcare sector, (EUR3 billion) from the EU budget. 11 September 2020, The EC agreed to add EUR6.2 billion to the EU 2020 budget to address the impact of the COVID-19-crisis and to fund inter alia the vaccine strategy. The revised budget increases payments for the Emergency Support Instrument (ESI) by EUR1.09 billion to ensure the development and deployment of a COVID-19 vaccine. The Commission will use this money as a down-payment for pre-ordering vaccine doses. 18 September 2020, EU allocates EUR150 million for the transport of essential medical items through the ESI and entered into a contract with Sanofi-GSK to purchase up to 300 million doses of the Sanofi-GSK vaccine; (iv) EUR63 million, EC secures EU access to Remdesivir (first European treatment authorized for COVID-19); (v) No amount/estimate: 8 October 2020, the EC approved a third contract with a pharmaceutical company, Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Once the vaccine has proven to be safe and effective against COVID-19, the contract allows EU Member States to purchase vaccines for 200 million people. They will also have the possibility to purchase vaccines for an additional 200 million people; (vi) 13 October 2020, EIB is providing EUR50 million to the Autonomous Community of Navarre, Spain to strengthen its capacity to respond to the COVID-19 health crisis. The EU bank financing will enable the Spanish region to adapt its healthcare infrastructure to meet the additional costs generated by the pandemic; (vii) No amount/estimate: 11 November 2020, In order to step up the fight against the COVID-19 pandemic and future health emergencies, The EC is taking the first steps towards building the European Health Union. The Commission is putting forward a set of proposals to strengthen the EU's health security framework, and to reinforce the crisis preparedness and response role of key EU agencies [update]; (viii) No amount/estimate: 17 November 2020, The EC approves a fifth contract with CureVac for the initial purchase of 225 million doses of potential vaccine; (ix) No amount/estimate: 25 November 2020, The EC approved a sixth contract under the EU Vaccines Strategy, with the pharmaceutical company Moderna. The contract provides for the initial purchase of 80 million doses on behalf of all EU Member States; (x) 7 December 2020: The Council of Europe adopted amendments to the directive on the common system of value added tax (VAT) to allow member states to temporarily exempt COVID-19 vaccines and testing kits, as well as closely related services, from VAT; (xi) 11 January 2021, The EC supports blood services to increase COVID-19 convalescent plasma collection with grants amounting to EUR36 million financed through the ESI [update]; (xii) No amount/estimate: 12 January 2020, The EC concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses [update].
|European Union||05B||05B - Income support||EUR||327,000,000||361,725,664|
|European Union||05B1||05B1 - Tax and contribution deferrals and policy changes||EUR|
|European Union||05B2||05B2 - Tax and contribution rates reduction||EUR|
|European Union||05B3||05B3 - Subsidies to individuals and households||EUR||179,000,000||198,008,850||OECD. http://www.oecd.org/coronavirus/en/#country-tracker (accessed 15 April 2020).||
Mobilized European Globalisation Adjustment Fund to support dismissed workers and those self-employed (up to EUR179 million available in 2020).
|European Union||05B4||05B4 - Subsidies to businesses||EUR||148,000,000||163,716,814||OECD. http://www.oecd.org/coronavirus/en/#country-tracker (accessed 15 April 2020); IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 21 May 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1221 (accessed 9 July 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1872 (accessed 15 October 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1007 (accessed 12 June 2020).||
(i) No amount/estimate: 19 March 2020, EU Commission intends to allow State aid for struggling businesses and enable Member States to use the full flexibility foreseen under State aid rules. On 8 May 2020, the European Commission adopted a second amendment to extend the scope of the State aid Temporary Framework to recapitalization and subordinated debt measures to further support the economy in the context of the coronavirus outbreak. The amended Temporary Framework will be in place until the end of December 2020, except for recapitalization measures which has an extended period by the end of June 2021. The Commission will assess before these dates if they need to be extended. 29 June 2020, third amendment to the State aid extends Temporary Framework to enable Member States to provide public support under the Temporary Framework to all micro and small companies, even if they were already in financial difficulty on 31 December 2019; 13 October 2020, EC has decided to prolong and extend the scope of the State aid Temporary Framework adopted on 19 March 2020 to support the economy in the context of the coronavirus outbreak. All sections of the Temporary Framework are prolonged for six months until 30 June 2021, and the section to enable recapitalization support is prolonged for three months until 30 September 2021; (ii) 8 June 2020, European Innovation Council (EIC) Accelerator Pilot fund issued grants of EUR148 million to innovative companies.
|European Union||05B5||05B5 - Indirect income support||EUR|
|European Union||05B6||05B6 - No breakdown (income support)||EUR|
|European Union||05C||05C - No breakdown (health and income support)||EUR||4,800,000,000||5,309,734,513||EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_997 (accessed 12 June 2020); ESF. https://esf.ie/en/covid-19/react-eu/ (accessed 5 September 2020).||
(i) June 2020, EUR4.8 billion (in grants from the amended 2020 annual EU budget) for REACT-EU that will provide additional funding for the most important sectors that will be crucial to lay the basis for a sound recovery. This will involve investment to support job maintenance, including through short-time work schemes and support for the self-employed. The funds can also be used to support job creation and youth employment measures, to health care systems and the provision of working capital and investment support for small and medium-sized enterprises. Such support will be available across economic sectors, including for the much-affected tourism and culture sectors. The additional support will also serve to invest in the European Green Deal and digital transition, as an enhancement to the significant investment in those areas that is already taking place through EU cohesion policy.
|Turkmenistan||03||03 - Direct long-term lending||TMT|
|Turkmenistan||03A||03A - Long-term lending||TMT|
|Turkmenistan||03B||03B - Forbearance||TMT|
|Turkmenistan||05||05 - Health and income support||TMT|
|Turkmenistan||05A||05A - Health support||TMT||IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 11 November 2020).||
(i) No amount/estimate: The Government announced that a bonus salary of 20%, 15%, and 10% will be given to healthcare professionals working in the remote rural facilities, frontline facilities, and other rural facilities, respectively.
|Turkmenistan||05B||05B - Income support||TMT|
|Turkmenistan||05B1||05B1 - Tax and contribution deferrals and policy changes||TMT|
|Turkmenistan||05B2||05B2 - Tax and contribution rates reduction||TMT|
|Turkmenistan||05B3||05B3 - Subsidies to individuals and households||TMT|
|Turkmenistan||05B4||05B4 - Subsidies to businesses||TMT|
|Turkmenistan||05B5||05B5 - Indirect income support||TMT|
|Turkmenistan||05B6||05B6 - No breakdown (income support)||TMT|
|Turkmenistan||05C||05C - No breakdown (health and income support)||TMT|
|European Central Bank||03||03 - Direct long-term lending||EUR|
|European Central Bank||03A||03A - Long-term lending||EUR|
|European Central Bank||03B||03B - Forbearance||EUR|